Molecule 2 Medicine
Molecule 2 Medicine Limited (M2M) is a private, UK based, biotechnology and pharmaceutical consulting company assisting global clients with the discovery, development and commercialisation of new human therapeutics. M2M provides clients with the technical skills required to run efficient drug discovery and drug development programs, along with the financial and commercial acumen and “back office” support to help their businesses succeed. M2M ensures that the growth of each client’s science is matched by their corporate development by providing guidance in such areas as venture capital/private equity capital raisings and interactions and negotiations with Pharma partners. M2M assist in creating new biotech businesses, providing operational assistance from the formation stage and guiding the evolution of companies on the right trajectory as they strive to develop new human therapeutics.